Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tenor Capital Management is a private hedge fund based in New York specializing in convertible arbitrage, litigation finance, and special situations investing. Founded by Robin Shah after spinning out from Putnam Lovell NBF’s relative value group around 2004, the firm manages approximately $7 billion USD as of early 2025. Its leadership includes experienced professionals such as Robin Shah (Chief Investment Officer) and Alexander Robinson (Head of Research). The firm invests across multiple sectors—including healthcare—but acts solely as an investor rather than a developer or operator within life sciences/biotech/pharma/healthcare fields. There are no indications that it develops drugs or medical technologies itself nor that it operates any clinical programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tenor Capital Management.